In one paragraphArticle in Kidney360, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Avi G AronovDepartment of Medicine, University of Illinois Chicago, Chicago, Illinois.
Ashish VermaSection of Nephrology, Department of Medicine, Boston Medical Center, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts.ORCID 0000-0001-9497-6327 Ana C RicardoDivision of Nephrology, Department of Medicine, University of Illinois Chicago, Chicago, Illinois.ORCID 0000-0001-8670-3644 Tanika N KellyDivision of Nephrology, Department of Medicine, University of Illinois Chicago, Chicago, Illinois.ORCID 0000-0002-7348-4451 Sushrut S WaikarSection of Nephrology, Department of Medicine, Boston Medical Center, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts.ORCID 0000-0003-4004-326 James P LashDivision of Nephrology, Department of Medicine, University of Illinois Chicago, Chicago, Illinois.ORCID 0000-0002-6580-4080 Anand SrivastavaDivision of Nephrology, Department of Medicine, University of Illinois Chicago, Chicago, Illinois.ORCID 0000-0002-8109-1420 CRIC Study Investigators
Funding
Central Hub for Kidney Precision MedicineU24DK114886 · NIDDK · UNIVERSITY OF WASHINGTON · PI Jonathan Himmelfarb, Matthias Kretzler · 2022 to 2026
$21.1MConProject-002U2CDK114886 · NIDDK · UNIVERSITY OF WASHINGTON · PI KRETZLER, MATTHIAS · 2017 to 2021
$21.0MUtility of Biomarkers of Rejection and Kidney Injury in Tailoring Liver Transplant ImmunosuppressionU01AI163081 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Justin Boike, Paolo Cravedi · 2021 to 2026
$11.3MFostering Academic Physician-Investigators Treating High Risk PopulationsR38HL155729 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI STEVEN M DUDEK, JEFFREY R JACOBSON · 2021 to 2026
$1.7MFunctional MRI to Identify High-risk CKD PhenotypesR01DK139321 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI Anand Srivastava · 2025 to 2026
$1.5MNon-Invasive Imaging Biomarkers to Identify a High-Risk Chronic Kidney Disease PhenotypeK23DK120811 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SRIVASTAVA, ANAND · 2020 to 2024
$1.0MNHLBI NIH HHS R38 HL155729NHLBI NIH HHS R38HL155729NIAID NIH HHS U01 AI163081NIDDK NIH HHS K23 DK120811NIDDK NIH HHS R01 DK139321NIDDK NIH HHS U24 DK114886NIDDK NIH HHS U2C DK114886
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
CKDESKDkidney failureproteinuriarisk factors
Identifiers
PMID40569689
PMCPMC12626656
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390